2Jones LC,Mont MA,Le TB,et al.Procoagulants and osteonecrosis.J Rheumat,2003,30:783-792.
3Glueck CJ,Freiberg RA,Wang P.Role of thrombosis in osteonecrosis.Curr Hemat Rep (Current Science),2003,2:417-422.
4Korompilias AV,Ortel TL,Urbaniak JR.Coagulation abnormalities in patients with hip osteonecrosis.Orthop Clin North Am,2004,35:265-271.
5Jones JP.Risk factors potentially activating intravascular coagulation and causing nontraumatic osteonecrosis,In:Urbaniank JR,Paul J,Je J,eds.Osteonecrosis etiology,diagnosis,and treatment.American Academy of Orthopaedic Surgeons,1997.89-96.
6Cosgriff SW.Thrombembolic complications associated with ACTH and cortisone therapy.JAMA,1951,147:924-926.
7Lee JS,Koo KH,Ha YC,et al.Role of Thrombotic and fibrinolytic disorders in osteonecrosis of the femoral head.Clin Orthop,2003,471:270-276.
8Bjorkman A,Svensson PJ,Hillarp A,et al.Factor V leiden and prothrombin gene mutation:risk factors for osteonecrosis of the femoral head in adults.Clin Orthop.2004,425:168-172.
9Bjorkman A,Burtscher IM,Svensson PJ,et al.Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee,Arch Orthop Trauma Surg,2005,125:51-55.
10Charalampos GZ,Geotge V,Eleni D,et al.Genetic background of Osteonecrosis:associated with thrombophilic mutations.Clin Orthop,2004,422:251-255.
